Viking Therapeutics VKTX
NASDAQ VKTX
$24.49 -1.34 (-5.19%)
As of: Oct 23, 2026 · 2:14 PM EDT

Viking Therapeutics (VKTX) Interest Coverage Ratio (2014 - 2015)

Updated

Viking Therapeutics' (VKTX) Interest Coverage Ratio was -13.08 for Q1 2015, compared with -81.42 a year earlier.

Analysis

Viking Therapeutics (VKTX) Interest Coverage Ratio (2014 - 2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,126.20 Bn 1,094.78 Bn 19.71 Bn -
2 Johnson & Johnson 633.36 Bn 553.22 Bn 17.30 Bn 28.50
3 AbbVie 504.51 Bn 477.62 Bn 12.70 Bn -
4 Merck 357.58 Bn 311.96 Bn 12.21 Bn -
5 Novartis Ag 289.65 Bn 253.64 Bn 11.24 Bn 10.28
6 Astrazeneca 264.97 Bn 238.66 Bn 12.86 Bn 7.27
7 Amgen 237.69 Bn 193.09 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.48 Bn 168.68 Bn 6.22 Bn -42.08
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Viking Therapeutics 2.85 Bn 325.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 -13.08
Mar 31, 2014 -81.42
API Access

Viking Therapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=VKTX&period=max&api_key=YOUR_API_KEY